HIV epidemic around the Baltic Sea
|
|
- Marcia Carpenter
- 5 years ago
- Views:
Transcription
1 HIV epidemic around the Baltic Sea Pauli Leinikki National Public Health Institute
2 Subtitles Statistics: what seems to have happened Dynamics: in what order Dissection: what actually happened Target friendly approach for interventions: why? HAART: hopes and challenges From case management to extended case management Future
3
4 HIV/AIDS in Romania
5 AIDS in Romania
6 HIV cases in 2002 Country: Finland Russia St Peterburg Latvia Estonia Lithuania Cases/million inhabitants
7 HIV rates(% adults)* Country Ukraine Estonia Russia Spain Netherland UK s Finland Rate Country South Africa India China Thailand USA Mexico Haiti Rate
8 Kaliningrad Kaliningrad St. Petersb Russia /8 mo
9 The mosaic genome of the Kaliningrad strain LTR gag KAL153 pol env nef subtype A subtype B
10 Local outbreaks around the Baltic Sea Kaliningrad 1996 St. Petersburg I 1997 Riga 1997 St Petersburg II 1998 Helsinki 1998 Estonia east 2001 Estonia general 2003
11
12
13
14 Reported HIV cases by age group in Nordic countries and Baltic states, HIV+ cases < <50 Age groups Nordic countries (N=2503) Baltic States (N=3594) EuroHIV
15 Characteristics of new HIV diagnoses in Baltic and Nordic countries, 2005 Countries HIV+ Per mln. % of young <25 % of female transmission mode Denmark % 26% MSM Finland % 29% Hetero Sweden % 42% Hetero Estonia % 37% IDU Latvia % 35% IDU Lithuania % 25% IDU
16 Rates of HIV per 10,000 pregnant women attending antenatal care in selected countries, HIV+ per 10,000 pregnant women Year Estonia Latvia Lithuania Finland Sweden
17 HIVprevalence among Intravenous drug users in several Baltic and Nordic countries 40 HIV prevalence (%) ,6 2, ,7 22 2,4 0 Denmark (2005) Finland (Helsinki, NEP, 2000) Sweden (Stockholm region prisons) Estonia (National, 2001) Latvia (National 2002) Latvia (Riga, 2002) Lithuania (National, 2003) Source: EuroHIV report Nr.70
18 IDUs are vulnerable to harm in many ways Multiple problems Medical Societal Indirect HIV/AIDS, Hepatitis
19 1200 Typical HIV outbreaks among IDU Annual incidence of HIV infection newly reported cases/million population 1000 I Example Incidence (log scale) Saturation
20 Risks associated to IDU: Spread of infectious diseases through sharing injection equipment (needles, syringes etc) Societal exclusion aggravated by discrimination Crime (to get the drugs) Accumulation of an ill prepared and excluded adult population into the society Undue hardening of societal norms
21 Hepatitis A in Finland Number of cases Tampere Year 2006
22 HCV seropositivity is strongly correlated with drug abuse in Finland: Proportion of seropositives: Risk groups: IDU 40 80% General population: Blood donors: <0.015% Health care workers: 0/567 Military recruits: 3/1063 Others: HIV positives 9% Prisoners: 28%
23 HIV and HCV infections among nonalcohol intoxicated drivers 1998 n Positive % HIV HCV (Leinikki, unpublished 1999).
24 Hepatitis C and time of injecting drug use Positive % Alle 1 v 1 2v 3 4v 5 7v 8 10v Yli 10v Time of injecting (years)
25 Opiate and ja amfetamine problem users (registry sampling resampling based estimates) (Partanen P. ym. 2004) Finland Capital area Opiate users Amfetamine Users
26 Drug users targeted information reach the population
27 Newly reported HIV cases among IDU 120 Annually reported cases Outbreak Year
28 Policy change implementation Network of Low Threshold Health Service Centers (LTHSC) for IDU in Finland 1997: 1 site in Helsinki Scale up of network coverage during Number Terveysneuvontapisteet of LTHSC
29 LTHSC in Finland Development of low threshold services targeted to IDU Hepatitis A & B epidemics HIV epidemic Infection risk project 1. LTHSC Government decision Change of vaccination program (HBV) Pharmacy recommendation Parlamentary policy paper Decision of the prosecutor New infectious disease statute legalising NEP Change of vaccination program (HAV)
30 Working principles of the Low Threshold Health Service Centers (LTHSC) for IDU in Finland: voluntary, not based on being drug free, personal information not recorded accessible to target group services include small scale health care provision, councelling & guidance to detoxification, VCT & HIVtesting, vaccinations (tetanus, HBV, HAV), condom distribution and exchange of injection equipment base for outreach work among IDU close collaboration with detox and primary health care services, social services and law enforcement
31 Injection equipment exchange at LTHSC : Working LTHSC Clients Visits Equipment exchanged ,1 milj. 1,4 milj. 1,8 milj. Equipment sold through the pharmacies:
32 Risk behaviour among Vinkki clients Pattern (sept 1) 1999 (Jun9) Has not borrowed S&N 55% 67% during the month Has lent to others 75% 44% Cleaned S&N after use 46% 89% High risk users 21% 3%
33 Tapauksia HIV Impact on HIV and Hepatitis epidemic in Finland Ruiskuhuumeisiin liittyvät HIV infektiot HCV Epidemia käynnistyi HCV ilmoitetut tapaukset (lähde : KTL INFE tartuntatautirekisteri) vuosi Number of LTHSC Terveysneuvontapisteet LTHSC network in Finland 21 municipalities > 30 sites 2004 statutory obligation for municipalities to provide services, Including inj.equipment exchange
34 Newly reported HIV cases in Finland (IDU) Annually reported cases Year
35 Hepatitis viral infections 1000 Hepatiitit Hep C Hep B
36
37 Also ART is possible: HIV + IDU / Helsinki area n=227 Needs ART n= 99 No ART, CD4 > 200 n=128 ART + n=79 no ART CD4 < 200 n=20 Pia Kivelä 2/2004
38 Injecting in Finnish prisons 1999 Ever injected drugs? 128/ % Injected insided prison (ever) 66/128 57% during the last 4 weeks 28/66 52% shared eq. during last shoot 51/ % first injected inside prison 9/ % P.Holmstrom et al. National Public Health Institute 1999
39
40 Impact of HIV in coinfections with HCV or HBV HCV/HIV: Singificant co morbidity, effect on LE, treatment interactions HBV/HIV:High virus production stage reemerges = rapid progress to LD
41 Case management: conventional Treatment of medical problems including medical prophylaxis of opportunistic infections Antiretroviral treatment Health promotion
42 Case management: comprehensive Medical CM including all aspects Social: employment, economic support, housing, education, child care, networking with peers etc
43 Case management: extended Medical CM Social CM Public Health CM: case finding, testing counceling primary and secondary prevention care of drug dependence, harm reduction rehabilitation rome care terminal care
44 Jonathan Mann 1985: AIDS is not just a disease of infected individuals. It very easily turns to a disease of the society. The symptoms of this disease are unjustified fears, oppression, violation of human rights and racism. We have seen the same symptoms in other contexts. Lets not let it happen again because of AIDS!
45 2005: AIDS is a disease of the society. It spreads through societal exclusion, discrimination, poverty, unrest and violence. Remedies include opennes, solidarity, nondiscriminating care, coherent family structures, societal and economic fairness
46
Drug Policy and the HIV Movement. SAULIUS CAPLINSKAS MD, PhD
Drug Policy and the HIV Movement SAULIUS CAPLINSKAS MD, PhD Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University 14th ECAD Mayors Conference Fighting Against Drugs - From Different
More informationHIV Expert Group Report for CSR
HIV Expert Group Report for CSR Gdansk P.Leinikki HIV is still a major public health threat made worse by the emerging link with MDR TB! Course of the epidemic different in different countries of the region:
More informationPrevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs
Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject
More informationHepatitis prevention in the context of HIV prevention point work in Latvia
Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationNDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention
More informationINTRAVENOUS INJECTING DRUG USE.
Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationGovernment of Canada Federal AIDS Initiative Milestones
HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for
More informationThe Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC
The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections
More informationHIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons
HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons Ministerial Meeting on Urgent response to the HIV/AIDS epidemics in the Commonwealth of Independent States Moscow, 31 March
More informationPromoting hepatitis B vaccination
Promoting hepatitis B vaccination Introduction Hepatitis B is a serious blood borne infection that can exacerbate hepatitis C infection, can cause serious liver damage and sometimes results in death. Hepatitis
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute
More informationTechnical Guidance Note for Global Fund HIV Proposals
Technical Guidance Note for Global Fund HIV Proposals UNAIDS I World Health Organization I 2011 Rationale for including this activity in the proposal The World Health Organization (WHO), the Joint United
More informationHIV Prevention Prioritization & Implementation Brief: Kaduna State
HIV Prevention Prioritization & Implementation Brief: Kaduna State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationKey issues for HIV testing and
Key issues for HIV testing and counselling in Europe Martin C Donoghoe Programme Manager HIV/AIDS, STI &Viral Hepatitis Programme WHO Europe Key issues for HIV testing & counselling in Europe HIV epidemics
More informationUNGASS COUNTRY PROGRESS REPORT Republic of Armenia
UNGASS COUNTRY PROGRESS REPORT Republic of Armenia Reporting period: January 2006 December 2007 I. Status at a glance The Armenia UNGASS Country Progress Report was developed under the overall guidance
More informationUNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,
U N A I D S B E S T P R A C T I C E C O L L E C T I O N Drug use and HIV/AIDS UNAIDS statement presented at the United Nations General Assembly Special Session on Drugs Joint United Nations Programme on
More informationHIV Prevention Prioritization & Implementation Brief: Gombe State
HIV Prevention Prioritization & Implementation Brief: Gombe State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationECDC and Spanish Ministry of Health workshop:
ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,
More informationViral Hepatitis Burden and Policy Directions in the European Region of WHO
Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all
More informationOverview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition
Overview of Evidence for Sterile Syringe Access Hilary McQuie Western Director Harm Reduction Coalition Working Definition of Harm Reduction Harm Reduction: A set of practical, public health strategies
More informationReview on HIV & Associated Infections in Latvia
Review on HIV & Associated Infections in Latvia Dr.Inga Upmace, Infectology Center of Latvia Second meeting on EG on HIV/AIDS and AI April 7, 2011, Riga Negative influences: Several reorganizations of
More informationSTI and HIV Prevention and Care among Sex Workers
Training Course in Sexual and Reproductive Health Research 2017 Module: Sexually transmitted infections, HIV/AIDS STI and HIV Prevention and Care among Sex Workers Annette Verster and Michelle Rodolph
More informationIntensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite
Intensified TB case finding among PLHIV and vulnerable population Identifying contacts Gunta Kirvelaite Riga East Clinical hospital, Centre for tuberculosis and lung diseases. Head of outpatient department.
More informationHIV Prevention Prioritization & Implementation Brief: Anambra State
HIV Prevention Prioritization & Implementation Brief: Anambra State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationHIV and Harm Reduction in Prisons
HIV and Harm Reduction in Prisons School of Public Health and Community Medicine Professor Kate Dolan Program of International Research and Training National Drug and Alcohol Research Centre UNSW, Sydney,
More informationTable Of Content. Outputs... 8
Table Of Content Expanding Network for Coordinated and Comprehensive Actions on HIV/AIDS Prevention among IDUs and Bridging Population... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Tervise
More informationUpdate on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by
More informationThe evolution of the HIV/AIDS outbreak among IDUs in Romania
The evolution of the HIV/AIDS outbreak among IDUs in Romania Romanian National Antidrug Agency Romanian National Focal Point on Drugs Andrei Botescu * Lisbon, 12 th October 2012 HIV outbreak among IDU
More informationHIV Prevention Prioritization & Implementation Brief: Benue State
HIV Prevention Prioritization & Implementation Brief: Benue State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationMethadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies
Methadone Treatment as a Harm Reduction Strategy, Gender Sensitive Programming and Evidence-based Strategies Wendee Wechsberg, PhD, Senior Director Substance Abuse Treatment Evaluations and Interventions
More informationHIV in Prison Situation in Frankfurt am Main
HIV in Prison Situation in Frankfurt am Main European Project ROME-SEMINAR, May 14.-15., 2008 Horst Herkommer, Sella Oneko Praxis Psychosoziale Beratung Frankfurt am Main Germany General remark: Situation
More informationHIV Prevention Prioritization & Implementation Brief: Lagos State
HIV Prevention Prioritization & Implementation Brief: Lagos State Introduction The HIV epidemic in Nigeria is complex, with substantial heterogeneity in HIV prevalence across different regions and diverse
More informationGLOBAL AIDS MONITORING REPORT
KINGDOM OF SAUDI ARABIA MINISTRY OF HEALTH GLOBAL AIDS MONITORING REPORT COUNTRY PROGRESS REPORT 2017 KINGDOM OF SAUDI ARABIA Submission date: March 29, 2018 1 Overview The Global AIDS Monitoring 2017
More informationHIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for
More informationFeedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014
Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Dr. Nicole Werner-Keišs Lisbon, 16.10.2014 Outline Background, scope and objectives
More informationDiagnosis of HIV and TB in the Finnish primary health care. Pekka Suomalainen M.D
Diagnosis of HIV and TB in the Finnish primary health care Inter-regional international conference Early diagnosis of HIV and associated infections, including TB, in the primary healthcare sector Petrozavodsk
More informationSAULIUS ČAPLINSKAS MD, PhD
Lithuanian experience in organization of intersectoral respose to HIV SAULIUS ČAPLINSKAS MD, PhD Director, Lithuanian AIDS Centre Assoc. Prof., Mykolas Romeris University, Vilnius, Lithuania www.aids.lt
More informationHarm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
More informationNew trends in harm reduction in Europe: progress made challenges ahead
New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm
More informationSex Work in Sub-Saharan Africa : Opportunities and Challenges
Sex Work in Sub-Saharan Africa : Opportunities and Challenges Dr Traore Isidore May 26, 2016 Definition of Sex Worker Female, male and transgender adults (18 years of age and above) who receive money or
More informationEG on HIV/AIDS for the NDPHS Progress report for 2006
EG on HIV/AIDS Sixth Meeting Berlin, Germany 14-15 March, 2007 Reference HIV/AIDS 6/7/1 Title Draft Progress Report of the HIV/AIDS EG for 2006 Submitted by HIV/AIDS EG Chair and ITA Summary / Note Requested
More informationECDC update to the EU Commission Think Tank on HIV/AIDS
ECDC update to the EU Commission Think Tank on HIV/AIDS Andrew Amato Head of HIV, STI and V. Hepatitis programme, ECDC Luxembourg, 10-11 December 2013 Outline Main ECDC reports published since last Think
More informationHIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia
HIV and Hepatitis Prevention Programmes in Eastern Europe Case Example: Georgia Nikoloz Chkhartishvili, MD, MS, PhD Deputy Executive Director for Research Infectious Diseases, AIDS and Clinical Immunology
More informationVersion for the Silent Procedure 29 April Agenda item January Hepatitis
Version for the Silent Procedure 29 April 2014 134th session EB134.R18 Agenda item 10.5 25 January 2014 Hepatitis The Executive Board, Having considered the report on hepatitis, 1 RECOMMENDS to the Sixty-seventh
More informationUNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision
UNGASS Declaration of Commitment on HIV/AIDS: Core Indicators revision Updated version following MERG recommendations Context In light of country reports, regional workshops and comments received by a
More informationHIV AND PEOPLE WHO INJECT DRUGS
UNAIDS 2017 HIV AND PEOPLE WHO INJECT DRUGS People who use and inject drugs are among the groups at highest risk of exposure to HIV, but remain marginalized and out of reach of health and social services.
More informationHepatitis and HIV Co-Infection: Situation in Ukraine.
2nd Central and Eastern European Meeting on Viral Hepatitis and Co-Infection with HIV Hepatitis and HIV Co-Infection: Situation in Ukraine. Pavlo Skala Associate Director: Policy & Partnership Ukraine
More informationNATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK
NATIONAL PRIORITIES FOR HIV/AIDS IN THE WORLD OF WORK KEY HIV STATISTICS IRAQ 585 HIV cases reported (June 2010) 288 Iraqis (49%) 297 Foreigners (51%) 83% male KEY HIV STATISTICS IRAQ Mode of transmission(n=585)
More informationEffective HIV & AIDS prevention strategies
Effective HIV & AIDS prevention strategies Prof Geoffrey Setswe Presentation at the PDM2008 Satellite Broadcast 5 July 2008 1 Structure of the presentation Evidence and types of evidence in HIV prevention
More informationGroups of young people in Uganda that need to be targeted with HIV interventions
Module 5: HIV/AIDS and young people - Adolescent health and development with a particular focus on sexual and reproductive health - Assignment Peter James Ibembe Reproductive Health Uganda, Kampala, Uganda
More informationDrug Use, Prisons and Compulsory Drug Treatment Centers
Drug Use, Prisons and Compulsory Drug Treatment Centers Sonia Bezziccheri, UNODC Regional Centre for East Asia and the Pacific Thai Satellite Meeting 19 April, 2009 Background In Thailand, drug offences
More informationCOUNTRY TABLE. MONTENEGRO.
EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI
More informationThe forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre
The forgotten group: a new HIV outbreak amongst people who inject drugs Patricia Anderson Lead CNS BBV Brownlee Centre No conflicts to declare Potted History 1981 Modern wave of drug misuse Glasgow soared
More informationBackground. Population/Intervention(s)/ Comparison/Outcome(s) (PICO)
updated 2012 Role of sterile injection equipment and outreach programmes for injecting drug users Q 6. Does the provision of sterile injection equipment to injecting drug users reduce injecting related
More informationKEY ELEMENTS FOR SUCCESSFUL INTERVENTION (1)
KEY ELEMENTS FOR SUCCESSFUL INTERVENTION (1) Mobilization of political will and commitment Good surveillance Learn and adapt from past experiences Unified national planning Rapid implementation KEY ELEMENTS
More informationHIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres
HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS
More informationOutline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs
Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs Joanna Buffington, MD, MPH Division of Viral Hepatitis National Immunization
More information2 nd Meeting on detecting and responding to outbreaks of HIV among PWID
2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases
More informationNDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 19 April, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen
NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 19 April, 2012 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen Relevance and context of the EG HIV/AIDS & AI work? Necessary to aim
More informationIFMSA Policy Statement Ending AIDS by 2030
IFMSA Policy Statement Ending AIDS by 2030 Proposed by IFMSA Team of Officials Puebla, Mexico, August 2016 Summary IFMSA currently acknowledges the HIV epidemic as a major threat, which needs to be tackled
More informationMethods: respondent driven sampling (RDS) was used to recruit PWID
RDS study among PWID in Kohtla-Järve, north-east of Estonia: prevalence of HIV and risk behaviours (an update, based on 216 study, and methodological considerations) Maris Salekešin Sigrid Vorobjov Methods:
More informationHIV EPIDEMIC UPDATE: FACTS & FIGURES 2012
HIV EPIDEMIC UPDATE: FACTS & FIGURES 2012 Number of Cases Note: In this surveillance report, HIV cases include persons reported with HIV infection (non-aids), advanced HIV (non-aids) and AIDS within a
More informationincreased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
More informationUNGASS COUNTRY PROGRESS REPORT LATVIA
UNGASS COUNTRY PROGRESS REPORT LATVIA Reporting period: January 2008 December 2009 Submission date: March 31, 2010 TABLE OF CONTENTS TABLE OF CONTENTS 1 I. ABBREVIATIONS 2 II. STATUS AT GLANCE 4 III. OWERVIEW
More informationMinutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012, Luxembourg
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Directorate C - Public Health and Risk Assessment C4 - Health determinants Minutes of the 18 th HIV/AIDS Think Tank Meeting 5 and 6 June 2012,
More informationKAZAKHSTAN. National Focal Point. Drug Abuse and Drug Dependence Treatment Situation. Territory : 2,717,300 km 2 Capital: Astana BASIC DATA
KAZAKHSTAN Territory : 2,717,300 km 2 Capital: Astana Map No. 3771 Rev. 6 UNITED NATIONS January 2004 BASIC DATA Total population (millions) 2009 15.5* Population under age15 (as % of total) 2010 23.8*
More informationU.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)
ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft) Project Title: HIV/AIDS prevention and care among injecting drug users and in prison settings in Estonia, Latvia and Lithuania Project Number: XEEJ20 Total
More informationProgram to control HIV/AIDS
90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,
More informationThe role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009
The role of UNODC in working law enforcement agencies to promote harm reduction IHRC, Bangkok, 23 April 2009 Drug control has focused mostly on law enforcement Public health which is the first principle
More informationCOSTA RICA KEY. Public health is the study of how diseases spread in a population and the measures used to control them.
COSTA RICA KEY Controlling the Pandemic: Public Health Focus Just 25 years since it was first reported, HIV/AIDS has become one of the world s greatest public health crises. More than 39 million people
More informationEmerging epidemics: Will they derail progress? Eastern/Central Europe
Emerging epidemics: Will they derail progress? Eastern/Central Europe Marieta Simonova, MD Clinic of Gastroenterology, Military Medical Academy Sofia, Bulgaria Disclosures Speaker/Adviser for AbbVie, Gilead,
More informationBOSTWANA KEY. Controlling the Pandemic: Public Health Focus
BOSTWANA KEY Controlling the Pandemic: Public Health Focus Just 25 years since it was first reported, HIV/AIDS has become one of the world s greatest public health crises. More than 39 million people worldwide
More informationGlobal, regional and national strategic planning for viral hepatitis prevention and control
Global, regional and national strategic planning for viral hepatitis prevention and control Dr Antons Mozalevskis WHO Regional Office for Europe VHPB Baltic Meeting 19 20 November 2015 Riga, Latvia Presentation
More informationPresenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin
Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public
More informationHIV in Russia. Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy
HIV in Russia Cost-effectiveness of Treating Injection Drug Users with Antiretroviral Therapy Elisa F. Long, M.S. Margaret L. Brandeau, Ph.D. Tatyana Vinichenko, M.D., M.P.A. Cristina M. Galvin, M.S. Swati
More informationPrevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don
More informationHIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS
POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES 2016 UPDATE Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care
More informationProgress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia
Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia 11 October 2011 Moscow, Russian Federation Zsuzsanna Jakab WHO Regional Director for Europe Millennium
More informationSupporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union
Supporting the Establishment of Prison- based Harm Reduction Policies and Programs in Eastern Europe and the Former Soviet Union Thomas Kerr 1, Matt Curtis 2, Ralf Jürgens 1 1 Canadian HIV/AIDS Legal Network
More informationIntegration of collaborative TB/HIV activities with harm reduction services
Integration of collaborative TB/HIV activities with harm reduction services Maryna Zelenskaya Ph D State service on HIV/AIDS and other socially diseases control, Head of Department on HIV/AIDS combating
More informationS P. Optimizing HIV/AIDS prevention programs: towards multidimensional allocative efficiency. Sergio Bautista Paola Gadsden Stefano M Bertozzi
ASAP Regional Training on Epidemiological and Economic Tools for HIV/AIDS Strategic Planning S P Optimizing HIV/AIDS prevention programs: towards multidimensional allocative efficiency Sergio Bautista
More informationMost recent data, analyses and feed-back from the 2016 DRID national updates
Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID
More informationUNGASS COUNTRY PROGRESS REPORT SINGAPORE
UNGASS COUNTRY PROGRESS REPORT SINGAPORE Submission date: 14 March 2008 Reporting period: January 2006 December 2007 I. Overview of the HIV/AIDS epidemic Singapore is categorized as a low-prevalence epidemic.
More informationImproving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal. Henrique Barros
Improving Access to Test and Counselling Services for Injection Drug Users: Most Recent Experience from Portugal Henrique Barros Ministério da Saúde HIV Testing Knowledge of HIV serostatus has been increasingly
More informationThe new German strategy on HIV, Hepatitis B, C and STI, an integrated approach. Ines Perea Ministry of Health, Germany
The new German strategy on HIV, Hepatitis B, C and STI, an integrated approach Ines Perea Ministry of Health, Germany Reasons for a new strategy in 2016 New international agreements (SDG s) Renewed political
More informationPrevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)
Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America
More informationReducing Harm or Producing Harm? Public Health Implications of Prosecuting HIV-positive People. Warren Michelow
Reducing Harm or Producing Harm? Public Health Implications of Prosecuting HIV-positive People Warren Michelow University of British Columbia School of Population and Public Health Outline Prosecuting
More informationPREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES
PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES Background In Wisconsin the two primary modes of HIV transmission are unsafe sexual behavior and nonsterile injection practices. More
More informationEG on Prison Health Third Meeting Paris France June 2007
EG on Prison Health Third Meeting Paris France 18-19 June 2007 Reference PH 3/7/3/ Title Submitted by Summary / Note Requested action Ongoing and Future Projects in Penal Institutions of Lithuania - For
More informationPerformance Management Plan Indicator Worksheet #1
Performance Management Plan Indicator Worksheet #1 Adapted from Investing in People: Indicators and Definitions (USAID) 1. Name and number of Strategic Objective: Reduced mother-to-child transmission of
More informationUnderstanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena
Understanding Key Populations: Removing Legal Barriers to Prisons Health and Human Rights. Nthabiseng Mokoena Key Populations The World health Organisation (WHO) defines key populations as groups who,
More informationPrevention services for minors in prisons
Prevention services for minors in prisons Iulia-Veronica Broasca Project Manager, ARAS-Romanian Association Against-AIDS Issues Up to 10% of all new HIV infections worldwide are attributed to injecting
More informationPrevention and control of hepatitis B and C in the European Region of WHO
Prevention and control of hepatitis B and C in the European Region of WHO Viral Hepatitis Prevention Board Dr Nedret Emiroglu WHO Regional Office for Europe Burden of viral hepatitis in the European Region
More informationVHPB MEETING ANTWERP 2014 ACHIEVEMENTS AND CHALLENGES IN PREVENTION AND CONTROL OF VIRAL HEPATITIS
POST-IT @ VHPB MEETING ANTWERP 2014 ACHIEVEMENTS AND CHALLENGES IN PREVENTION AND CONTROL OF VIRAL HEPATITIS East challenges Risk group vaccination problems Problems of anti-vaccine lobby Importance of
More informationViral Hepatitis. WHO Regional Office for Europe July 2013
Viral Hepatitis WHO Regional Office for Europe July 2013 What is Hepatitis? Hepatitis is a viral infection that causes inflammation of the liver There are five main types of viral hepatitis: A, B, C, D,
More informationFIGHTING HIV IN ESTONIA IN 2006 AND Aire Trummal, Liilia Lõhmus, Kristi Rüütel
FIGHTING HIV IN ESTONIA IN 2006 AND 2007 Aire Trummal, Liilia Lõhmus, Kristi Rüütel Tallinn 2008 TABLE OF CONTENTS INTRODUCTION... 3 1. TRENDS OF HIV TRANSMISSION IN ESTONIA... 4 2. STRUCTURES FOR IMPLEMENTING
More information5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives
Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral
More information